CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −824 | $27.26 | $22K | 14,822 |
| 2024-03-05 | Quinn Grainne EVP, Chief Medical Officer | Grant or award | +9,028 | $27.26 | $246K | 23,850 |
| 2024-03-05 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −4,695 | $27.26 | $128K | 19,155 |
| 2024-03-05 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,583 | 0 | ||
| 2024-03-05 | Farrington Thomas EVP and CIO | Option exercise | +1,693 | $27.26 | $46K | 4,516 |
| 2024-03-05 | Farrington Thomas EVP and CIO | Shares withheld for taxes | −627 | $27.26 | $17K | 3,889 |
| 2024-03-05 | Farrington Thomas EVP and CIO | Grant or award | +9,652 | $27.26 | $263K | 13,541 |
| 2024-03-05 | Farrington Thomas EVP and CIO | Shares withheld for taxes | −4,033 | $27.26 | $110K | 9,508 |
| 2024-03-05 | Farrington Thomas EVP and CIO | Option exercise · Restricted Stock Units | −1,693 | 0 | ||
| 2024-03-05 | Andersen Svend EVP & President CHCI | Option exercise | +3,411 | $27.26 | $93K | 72,152 |
| 2024-03-05 | Andersen Svend EVP & President CHCI | Grant or award | +19,445 | $27.26 | $530K | 91,597 |
| 2024-03-05 | Andersen Svend EVP & President CHCI | Option exercise · Restricted Stock Units | −0 | 3,411 | ||
| 2024-03-05 | Brown Julia M Director | Grant or award · Restricted Stock Units | +5,548 | 5,548 | ||
| 2024-03-01 | Willis Robert EVP & CHRO | Purchase | +371 | $26.30 | $10K | 25,476 |
| 2024-02-29 | Ives Alison EVP & Chief Scientific Officer | Purchase | +1,545 | $26.44 | $41K | 12,446 |
| 2024-02-29 | Willis Robert EVP & CHRO | Purchase | +6,000 | $25.87 | $155K | 25,105 |
| 2024-02-29 | Lockwood-Taylor Patrick CEO | Purchase | +9,500 | $26.54 | $252K | 20,500 |
| 2023-11-24 | Willis Robert EVP & CHRO | Purchase | +5,550 | $31.01 | $172K | 19,105 |
| 2023-11-16 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,040 | $29.34 | $60K | 10,901 |
| 2023-11-16 | Ives Alison EVP & Chief Scientific Officer | Purchase | +2,040 | $29.34 | $60K | 10,380 |
Page 21 of 27 · 524 trades